AQUESTIVE THERAPEUTICS INC reports a Return on Equity (ROE) of 202.36%.

What is AQST's dividend yield?

AQUESTIVE THERAPEUTICS INC offers a dividend yield of 0.00%.

What is AQST's Deepscope Quality Score?

Deepscope rates AQST's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy AQST?

Deepscope's AI Timing Score for AQST is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does AQST belong to?

AQUESTIVE THERAPEUTICS INC is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange.

AQST (NASDAQ) 株価分析 | AQUESTIVE THERAPEUTICS INC

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-03 | FS: 2026-03-31)

AQST

AQUESTIVE THERAPEUTICS INC

USD 4.03

0.10 (2.54%) Day Change

Watchlist Portfolio Compare Chart

-1.19

D/E

202.4%

ROE

-48.8%

ROA

0.00%

Div Yield

AQUESTIVE THERAPEUTICS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 4.03 Price 0.10 (2.54%) Day Change	NEWS SCORE: 90

AQST, ファンダメンタルスコアはnot quite good ( ファンダメンタル = 54) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROAが低い
ROEが昨年度比で低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...

Deepscope 分析

51%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	90
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	4.03
PBV / Sector	-14.48 / 2.65
Earning Per Share	-0.56

PE / Sector	N/A / 22.64
PEG or PE/Growth / Sector	N/A / 0.11
Average 1M Daily Value	7.73 M
Average 1W Daily Value	6.07 M

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

64%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-137.08 / 15.98
NPM Average (%) / Sector	-106.30 / -16.38
NPM Change Average (%) / Sector	106.16 / 113.39 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-48.83 / 8.16
ROA Average (%) / Sector	-50.72 / 2.38
ROA Change Average (%) / Sector	36.34 / 108.63 GREAT
ROE (%) / Sector	202.36 / -0.19 GREAT
ROE Average (%) / Sector	115.58 / 7.40 GREAT
ROE Change Average (%) / Sector	257.35 / 371.95 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.54
Dividend Average (%) / Sector	N/A / 3.08
Dividend Change Average (%) / Sector	N/A / 15.11

登録情報

Analyze Date	2026-06-04 09:23:35
Symbol	AQST
Name	AQUESTIVE THERAPEUTICS INC
Sector	Healthcare >> Drug Manufacturers - Specialty & Generic
Market	NASDAQ
Listed Shares	125.45 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	493.02 / 9,480.84

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 30 Technology Drive, Warren, NJ, United States, 07059

Phone: 908 941 1900

Website: https://www.aquestive.com

Employees: 147

Sector: Healthcare >> Drug Manufacturers - Specialty & Generic

Description: Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; EMYLIF, an oral film formulation of riluzole; ONDIF, an oral soluble film formulation of ondansetron; SYMPAZAN, an oral soluble film formulation of clobazam used for the treatment of seizures associated with a rare, intractable form of epilepsy; KYNMOBI, a sublingual film formulation of apomorphine; and AZSTARYS, an fda-approved, once-daily product for the treatment of ADHD in patients age 6 years or older. The company's proprietary pipeline products include Anaphylm, an epinephrine sublingual film, which is in phase 3 clinical trial for the emergency treatment of allergic reactions, including anaphylaxis; and AQST-108, a topical gel that is in phase 2 clinical trial for the treatment of alopecia areata. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders; and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.